Table 1 Sampled antiretroviral medicines from medicine distribution outlets and number of samples selected and tested for confirmatory testing
From: Quality of selected anti-retroviral medicines: Tanzania Mainland market as a case study
Product name | Samples collected and screened | Confirmatory test | |||
|---|---|---|---|---|---|
Samples collected | Samples screened and passed | Samples Failed | Samples eligible for confirmatory | Samples selected and tested | |
Efavirenz | 66 | 66 | 0 | 7 | 14 |
Nevirapine tablets | 34 | 34 | 0 | 4 | 7 |
Lamivudine tablets | 10 | 10 | 0 | 1 | 10 |
Zidovudine tablets | 2 | 2 | 0 | 1 | 2 |
Tenofovir Disoproxil Fumarate tablets | 5 | 5 | 0 | 1 | 5 |
Lamivudine/Zidovudine tablets | 70 | 70 | 0 | 7 | 7 |
Abacavir Sulphate tablets | 16 | 16 | 0 | 2 | 4 |
Lopinavir/Ritonavir tablets | 18 | 12 | 7 | 9 | 9 |
Tenofovir Disoproxil Fumarate /Emtricitabine tablets | 14 | 14 | 0 | 2 | 4 |
Tenofovir Disoproxil Fumarate /Lamivudine/Efavirenz tablets | 29 | 29 | 0 | 3 | 6 |
Lamivudine/Zidovune/Nevirapine tablets | 73 | 73 | 7 | 14 | 14 |
Lamivudine/Stavudine/Nevirapine tablets | 66 | 59 | 0 | 10 | 10 |
Tenofovir Disoproxil Fumarate /Efavirenz/Emtricitabine tablets | 27 | 27 | 0 | 3 | 8 |
Total | 430 | 416 | 14 | 61 | 100 |